Ana Catarina Fonseca: The Persistent Gaps in Blood Pressure Guideline Achievement After Stroke
Ana Catarina Fonseca, Member of Scientific Advisory Group on Neurology at European Medicines Agency, Associate Editor – Cerebrovascular Diseases at Karger Publishers, Member Board of Directors at European Stroke Organisation, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Stroke Journal, adding:
”In a large contemporary secondary stroke prevention trial, over one-third of participants did not achieve less-stringent pre-2022 BP guideline targets, and 70% did not achieve current ESO guideline targets.
New approaches are needed to improve guideline implementation in practice.”
Title: Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial
Authors: Pádraig Synnott, Cathal Walsh, Christian Weimar, Francisco Purroy, Chris Price, Ana Catarina Fonseca, Michael Hill, Dalius Jatuzis, Janika Kõrv, Christina Kruuse, Robert Mikulík, Paul Nederkoorn, Anna Członkowska, Urs Fischer, Darius G. Nabavi, Joseph Harbison, Tim Cassidy, Margaret O’Connor, Helle Klingenberg Iversen, Katja Adie, Robin Lemmens, Peter J. Kelly
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?
-
Sep 20, 2026, 00:50A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM